Back

Choose your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia-Herzegovina Bosnia-Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Germany Germany Flag Hungary Hungary Flag Italy Italy Flag Kosovo Kosovo Flag Latvia Latvia Flag Lithuania Lithuania Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Montenegro Montenegro Flag Poland Poland (Lab) Flag Portugal Portugal (Lab) Flag Romania Romania (Lab) Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Spain Spain (Lab) Flag Switzerland Switzerland (Lab) Flag Sweden Sweden Flag Turkey Turkey (Lab) Flag United Kingdom United Kingdom

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
1501 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 46
1502 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 64
1503 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 71
1504 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 49
1505 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 62
1506 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 63
1507 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 71
1508 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 72
1509 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 33
1510 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 3
1511 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
1512 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 16
1513 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 66
1514 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 64
1515 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 71
1516 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 62
1517 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 48
1518 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 62
1519 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 48
1520 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 73
1521 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 69
1522 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 79
1523 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 54
1524 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 44
1525 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 63
1526 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 56
1527 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
1528 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 72
1529 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
1530 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 64
1531 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
1532 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 70
1533 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 66
1534 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 88
1535 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 67
1536 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 52
1537 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 57
1538 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 62
1539 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 36
1540 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 61
1541 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 11
1542 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Germany 61
1543 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb2 Hematology 2022 Standard Therapy Poland 62
1544 Apheresis Allogeneic Myelodysplastic Syndrome Rc Hematology 2022 Standard Therapy Poland 3
1545 Apheresis Allogeneic Myelodysplastic Syndrome With Excess Blasts 1 Hematology 2022 Standard Therapy Poland 59
1546 Apheresis Allogeneic Myelodysplastic Syndrome With Excess Blasts 2 Hematology 2022 Standard Therapy Poland 67
1547 Apheresis Allogeneic Myelodysplastic Syndrome With Fibrosis Hematology 2022 Standard Therapy Poland 72
1548 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 58
1549 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 69
1550 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 57
1551 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 64
1552 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 73
1553 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 67
1554 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 66
1555 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 69
1556 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 60
1557 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 69
1558 Apheresis Allogeneic Myelofibrosis Post Essential Thrombocythemia Hematology 2022 Standard Therapy Poland 64
1559 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 58
1560 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 72
1561 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 73
1562 Apheresis Autologous Myeloma Hematology 2022 Standard Therapy Germany 54
1563 Apheresis Allogeneic Myeloma Multiplex Hematology 2022 Standard Therapy Poland 31
1564 Apheresis Allogeneic Myeloproliferative Neoplasms With Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 59
1565 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 50
1566 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 37
1567 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 64
1568 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 59
1569 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 21
1570 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 38
1571 Apheresis Autologous Nodular Lymphocyte Predominant Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 31
1572 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 73
1573 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 61
1574 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 53
1575 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 18
1576 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 28
1577 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 55
1578 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 59
1579 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 52
1580 Apheresis Allogeneic Osteomyelofibrosis Hematology 2022 Standard Therapy Poland 59
1581 Apheresis Allogeneic Osteomyelofibrosis Hematology 2022 Standard Therapy Poland 59
1582 Apheresis Allogeneic Other Immune System Hematology 2022 Standard Therapy Poland 46
1583 Apheresis Allogeneic Other Malignancy Hematology 2022 Standard Therapy Poland 72
1584 Apheresis Allogeneic Peripheral T-Cell Lymphoma Hematology 2022 Standard Therapy Poland 32
1585 Apheresis Allogeneic Plasma Cell Disorder Hematology 2022 Standard Therapy Poland 56
1586 Apheresis Allogeneic Plasma Cell Leukemia Hematology 2022 Standard Therapy Poland 58
1587 Apheresis Allogeneic Post-Essential Thrombocythemia-Myelofibrosis Hematology 2022 Standard Therapy Poland 64
1588 Apheresis Allogeneic Post–Polycythemia Vera Myelofibrosis (Post-Pv Mf)  Hematology 2022 Standard Therapy Poland 48
1589 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 65
1590 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 65
1591 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 58
1592 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 39
1593 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 67
1594 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 37
1595 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 69
1596 Apheresis Allogeneic Primary Myelofibrosis Hematology 2022 Standard Therapy Poland 62
1597 Apheresis Allogeneic Primary Myelofibrosis Hematology 2022 Standard Therapy Poland 66
1598 Apheresis Allogeneic Primary Myelofibrosis Hematology 2022 Standard Therapy Poland 70
1599 Apheresis Allogeneic Primary Refractory T-Cell Lymphoma Hematology 2022 Standard Therapy Poland 55
1600 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 58